EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Survival Benefit of Adjuvant Treatment with Huaier Granules Plus Lenvatinib in Hepatocellular Carcinoma Patients with Tumors Greater Than 5 cm After Radical Hepatectomy

Cong Liu, Ying Bai, Qingquan Bai, Maria A Parra, Liangliang Zhao, Jiashu Zou, Qian Cao, Haoling Liu, Haiyan Yang

Journal of Hepatocellular Carcinoma · 2025-07 · Volume 12 · 1495-1507

DOI: 10.2147/jhc.s515730 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hepatocellular Carcinoma, 2025-07. Verfasst von Cong Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hepatic and Liver Transplantation Division, Department of Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, People's Repub…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The postoperative recurrence of hepatocellular carcinoma (HCC), influenced by various factors, including microvascular invasion (MVI), plays a critical role in the long-term prognosis following radical liver resection. This study investigated potential adjuvant treatment strategies for HCC patients who exhibit multiple recurrence factors after radical resection.

Methods

A retrospective analysis was conducted on data from 243 patients who underwent radical resection for HCC and exhibited high recurrence factors at the First Affiliated Hospital of Harbin Medical University. Some of these patients received postoperative adjuvant therapy with Huaier granules, lenvatinib, or a combination of both, while others did not receive any postoperative adjuvant therapy.

Results

Survival analysis showed a more favorable prognosis in the adjuvant Huaier granules and lenvatinib groups (all P < 0.05). Furthermore, when compared to monotherapy, the combination therapy group exhibited significantly improved overall survival (OS) (P = 0.001) and disease-free survival (DFS) (P = 0.001). Multivariate Cox regression analysis demonstrated that the addition of Huaier granules to lenvatinib was an independent protective factor associated with improved OS (hazard ratio (HR) = 0.777, 95% confidence interval (CI) = 0.616-0.980, P = 0.033) and DFS (HR = 0.753, 95% CI = 0.615-0.920, P = 0.006).

Conclusion

In this retrospective analysis, the combination of Huaier granules and lenvatinib as postoperative adjuvant therapy was associated with improved long-term prognosis in patients at high risk of HCC recurrence.

Schlagwörter

Stichwörter der Autor:innen

Huaier granuleshepatocellular carcinomalenvatinibprognosisrecurrence

Autor:innen und Institutionen

  • Hepatic and Liver Transplantation Division, Department of Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
  • Department of Hepatobiliary Surgery, Weihai Central Hospital Affiliated to Qingdao University, Weihai, People's Republic of China.
  • Future Medical Laboratory, The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
  • Department of Hepatology & Gastroenterology, Charité Universitätsmedizin Berlin, Campus Virchow-Klinikum and Campus Charité Mitte, Berlin, 13353, Germany.
  • Cancer Research Center, School of Medicine, Xiamen University, Xiamen, People's Republic of China.
  • Transplant Surgery Division, Department of Surgery, Johns-Hopkins Hospital, Baltimore, MD, USA.

Zitieren

APA

Liu, C., Bai, Y., Bai, Q., Parra, M. A., Zhao, L., Zou, J., Cao, Q., Liu, H., & Yang, H. (2025). Survival Benefit of Adjuvant Treatment with Huaier Granules Plus Lenvatinib in Hepatocellular Carcinoma Patients with Tumors Greater Than 5 cm After Radical Hepatectomy. Journal of Hepatocellular Carcinoma, Volume 12, 1495-1507. https://doi.org/10.2147/jhc.s515730

Vancouver

Liu C, Bai Y, Bai Q, Parra MA, Zhao L, Zou J, et al. Survival Benefit of Adjuvant Treatment with Huaier Granules Plus Lenvatinib in Hepatocellular Carcinoma Patients with Tumors Greater Than 5 cm After Radical Hepatectomy. Journal of Hepatocellular Carcinoma. 2025;Volume 12:1495-1507. doi:10.2147/jhc.s515730

BibTeX
@article{Liu2025,
  author = {Liu, Cong and Bai, Ying and Bai, Qingquan and Parra, Maria A and Zhao, Liangliang and Zou, Jiashu and Cao, Qian and Liu, Haoling and Yang, Haiyan},
  title = {Survival Benefit of Adjuvant Treatment with Huaier Granules Plus Lenvatinib in Hepatocellular Carcinoma Patients with Tumors Greater Than 5 cm After Radical Hepatectomy},
  journal = {Journal of Hepatocellular Carcinoma},
  year = {2025},
  volume = {Volume 12},
  pages = {1495--1507},
  doi = {10.2147/jhc.s515730}
}
Kostenlos starten →